For employers & institutions
Cancer arrives at work before it arrives at a hospital.
Someone takes leave they cannot explain. Then months of disorganised absence while a family tries to coordinate care nobody is coordinating. Cover changes both halves.
A camp with a denominator. How many screened, how many positive, and, the number almost nobody measures, how many actually reached a diagnosis.
What the contract buys
Four things, none of them a benefit brochure
Risk assessment & on-site screening
- Cancer risk assessment available to every employee, at no charge to them
- On-site camps designed for your workforce's actual exposure profile, tobacco and areca nut in a manufacturing plant is a different programme from a desk-based office
- Oral, breast and cervical screening as the default trio, because that is where India's burden and detectability overlap
- Tobacco and areca-nut cessation, run as a programme rather than a poster
Second opinion & navigator
- A written second-opinion entitlement for any employee or dependant diagnosed, theirs to use anywhere, including against a plan we did not write
- A named OnKommon Navigator engaged from diagnosis, coordinating appointments, records, tests and recall
- The cost desk: total course costing, clinically equivalent cheaper medicines, and the government schemes they are entitled to
Return-to-work
- Functional and fatigue assessment before a return date is agreed
- A phased-return plan your HR team can actually implement
- The documentation an Indian employer needs, written to be usable rather than defensive
- Ongoing rehabilitation through our own physiotherapy service
Quarterly utilisation report
- How many employees used the assessment, the camps, the opinion entitlement
- Camp yield: screened, positive, and, the number that matters, reached a diagnosis
- Aggregate exposure and risk profile of the workforce, to shape next year's programme
- Aggregate and anonymised. Always.
The line we do not cross
The employee is our patient, not yours
This is the clause that makes an employer programme usable. Without it, employees do not participate, and a screening programme nobody trusts is worse than none, because it produces a false sense that the risk has been managed.
You never receive
A diagnosis. A screening result. An attendance record at any clinic. A name attached to any finding. A list of who used the service.
You receive
Aggregate, anonymised utilisation and yield. And, where a fitness determination is separately contracted, only the determination, never the clinical detail behind it.
How a case moves
Pricing
Per employee, per year
Banded by headcount and by which of the four components you take. Annual contract, invoiced to the organisation.
| Band | Per employee / year | Includes |
|---|---|---|
| Assess | ₹600 | Risk assessment for every employee, one on-site camp a year, cessation programme, quarterly report. |
| Assess + Opinion | ₹1,000 | The above, plus a written second-opinion entitlement for any employee or dependant diagnosed. |
| Full cover | ₹1,500 | The above, plus navigator engagement from diagnosis, the cost desk, and return-to-work assessment. |
Screening investigations performed at a camp are billed at partner diagnostic rates, quoted per programme before it runs, they are not inside the per-employee fee. Molecular testing, imaging, treatment and procedures are billed to the patient or their insurer by whoever provides them. This is a service contract, not an insurance product: it does not reimburse treatment cost.
Why an employer, specifically
You have something a health system does not
A defined population, a way to reach every one of them, and a reason they will turn up. Public screening programmes spend most of their effort on those two problems.
We make no claim about outcomes or cost savings, and we will not present one. The quarterly report tells you what actually happened, how many were screened, how many findings, and how many reached a diagnosis. Judge it on that.
Start with one camp
Run a single on-site screening camp before committing to an annual contract. You will see the yield, your people will see what it is like, and we will both find out whether this is worth doing at your scale.